Health benefits and risks of fermented foods—the PIMENTO initiative

Smilja Todorovic; Asli Akpinar; Ricardo Assunção; Cornelia Bär; Simona L. Bavaro; Muzeyyen Berkel Kasikci; Domínguez-Soberanes, Julieta; Vittorio Capozzi; Paul D. Cotter; Eun-Hee Doo; Burcu Gündüz Ergün; Mustafa Guzel; Hayriye S. Harsa; Emre Hastaoglu; Christèle Humblot; Bahtir Hyseni; Muge I. Hosoglu; Aline Issa; Barçın Karakaş-Budak; Sibel Karakaya

doi:10.3389/fnut.2024.1458536

Health benefits and risks of fermented foods—the PIMENTO initiative

Journal

Frontiers in Nutrition

ISSN

2296-861X

Date Issued

2024

Author(s)

Smilja Todorovic

Asli Akpinar

Ricardo Assunção

Cornelia Bär

Simona L. Bavaro

Muzeyyen Berkel Kasikci

Domínguez-Soberanes, Julieta

Facultad de Ingeniería - CampAGS

Vittorio Capozzi

Paul D. Cotter

Eun-Hee Doo

Burcu Gündüz Ergün

Mustafa Guzel

Hayriye S. Harsa

Emre Hastaoglu

Christèle Humblot

Bahtir Hyseni

Muge I. Hosoglu

Aline Issa

Barçın Karakaş-Budak

Sibel Karakaya

Harun Kesenkas

Erhan Keyvan

Ibrahim E. Künili

Mary-Liis Kütt

Marta Laranjo

Sandrine Louis

Fani T. Mantzouridou

Antonia Matalas

Baltasar Mayo

Sandra Mojsova

Arghya Mukherjee

Anastasios Nikolaou

Fatih Ortakci

Diana Paveljšek

Giancarlo Perrone

Eugenia Pertziger

Dushica Santa

Taner Sar

Isabelle Savary-Auzeloux

Clarissa Schwab

Małgorzata Starowicz

Marko Stojanović

Michail Syrpas

Jyoti P. Tamang

Oktay Yerlikaya

Birsen Yilmaz

Jeadran Malagon-Rojas

Seppo Salminen

Juana Frias

Christophe Chassard

Guy Vergères

Type

text::journal::journal article

DOI

10.3389/fnut.2024.1458536

URL

https://scripta.up.edu.mx/handle/20.500.12552/11503

Abstract

Worldwide, fermented foods (FF) are recognized as healthy and safe. Despite the rapid increase of research papers, there is a lack of systematic evaluation of the health benefits and risks of FF. The COST Action CA20128 “Promoting innovation of fermented foods” (PIMENTO) aims to provide a comprehensive assessment on the available evidence by compiling a set of 16 reviews. Seven reviews will cover clinical and biological endpoints associated with major health indicators across several organ systems, including the cardiovascular, gastrointestinal, neurological, immune, and skeletal systems. Nine reviews will address broader biological questions associated with FF including bioactive compounds and vitamin production, nutrient bioavailability and bioaccessibility, the role of FF in healthy diets and personalized nutrition, food safety, regulatory practices, and finally, the health properties of novel and ethnic FF. For each outcome assessed in the reviews, an innovative approach will be adopted based on EFSA’s published guidance for health claim submissions. In particular, each review will be composed of three parts: (1) a systematic review of available human studies; (2) a non-systematic review of the mechanism of action related to the clinical endpoints measured by the human studies identified in part 1; and (3) a non-systematic review of the characterization of the FF investigated in the human studies identified in part 1. The evidence and research gaps derived from the reviews will be summarized and published in the form of a strategic road map that will pave the way for future research on FF.